Zobrazeno 1 - 10
of 124
pro vyhledávání: '"transduction cascades"'
Autor:
Lüthen, Mareen
Das normale Kolonepithel weist eine strenge Zellhierarchie auf, die aus bekannten Zelltypen besteht. Bei Darmkrebs (CRC) ist die Struktur weniger konserviert und nicht gut verstanden. Krebsauslösende Mutationen können die Prävalenz von Zelltypen v
Externí odkaz:
http://edoc.hu-berlin.de/18452/28402
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2005 Jan 01. 102(2), 331-336.
Externí odkaz:
https://www.jstor.org/stable/3374245
Autor:
Berlak, Mareike
Anaplastic lymphoma kinase (ALK) is a driving oncogene in neuroblastoma and mutated in 8% - 10% of neuroblastoma cases. Despite high-risk neuroblastoma patients being treated with an intensive multimodal therapy, up to 60% of these patients relapse a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb08c8bb4b84a1855cf114b04ddc737a
Publikováno v:
International Journal of Biological Sciences
Enolase 1 (ENO1) is a moonlighting protein, function as a glycolysis enzyme, a plasminogen receptor and a DNA binding protein. ENO1 play an important role in the process of cancer development. The transcription, translation, post-translational modify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e2cafa006b31d1f10d4a2b7e16660f9
http://europepmc.org/articles/PMC8495383
http://europepmc.org/articles/PMC8495383
Autor:
Giuseppe ePalmieri, MariaNeve eOmbra, Maria eColombino, Milena eCasula, MariaCristina eSini, Antonella eManca, Panagiotis ePaliogiannis, Paolo Antonio eAscierto, Antonio eCossu
Publikováno v:
Frontiers in Oncology, Vol 5 (2015)
Molecular mechanisms involved in pathogenesis of malignant melanoma have been widely studied and novel therapeutic treatments developed in recent past years. Molecular targets for therapy have mostly been recognized in the RAS-RAF-MEK-ERK and PI3K-AK
Externí odkaz:
https://doaj.org/article/efc35eeaad824ffeaf40c80837ebed7b
Publikováno v:
OncoTargets and Therapy, Vol 2016, Iss Issue 1, Pp 3163-3169 (2016)
Jan-Niclas Mumm, Alexandra C Kölbl, Udo Jeschke, Ulrich Andergassen Department of Obstetrics and Gynaecology, Ludwig-Maximilians University of Munich, Munich, Germany Background: Triple-negative breast cancer (TNBC) is a rather aggressive form of br
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::dacf1f581be9d92d9201211460e3ec74
https://www.dovepress.com/do-signal-transduction-cascades-influence-survival-in-triple-negative--peer-reviewed-article-OTT
https://www.dovepress.com/do-signal-transduction-cascades-influence-survival-in-triple-negative--peer-reviewed-article-OTT
Publikováno v:
OncoTargets and therapy
Jan-Niclas Mumm, Alexandra C Kölbl, Udo Jeschke, Ulrich Andergassen Department of Obstetrics and Gynaecology, Ludwig-Maximilians University of Munich, Munich, Germany Background: Triple-negative breast cancer (TNBC) is a rather aggressive form of br
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eedd6809f5de6e95a78e7a166564623
http://europepmc.org/articles/PMC4888713
http://europepmc.org/articles/PMC4888713
Recent technological and analytical breakthroughs in genomics and proteomics have deepened our understanding related to the multifaceted nature of cancer. Because of therapeutically challenging nature of cancer, there has been a renewed interest in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10007::8e953d18d45c6715e475e2b2116d0c5f
https://hdl.handle.net/20.500.11831/621
https://hdl.handle.net/20.500.11831/621
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Antonio Cossu, Maria Colombino, MariaCristina Sini, Antonella Manca, Milena Casula, Panagiotis Paliogiannis, Giuseppe Palmieri, Paolo A. Ascierto, MariaNeve Ombra
Publikováno v:
Frontiers in Oncology
Frontiers in oncology 5 (2015). doi:10.3389/fonc.2015.00183
info:cnr-pdr/source/autori:Palmieri G.; Ombra M.; Colombino M.; Casula M.; Sini M.; Manca A.; Paliogiannis P.; Ascierto P.A.; Cossu A./titolo:Multiple molecular pathways in melanomagenesis: Characterization of therapeutic targets/doi:10.3389%2Ffonc.2015.00183/rivista:Frontiers in oncology/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume:5
Frontiers in Oncology, Vol 5 (2015)
Frontiers in oncology 5 (2015). doi:10.3389/fonc.2015.00183
info:cnr-pdr/source/autori:Palmieri G.; Ombra M.; Colombino M.; Casula M.; Sini M.; Manca A.; Paliogiannis P.; Ascierto P.A.; Cossu A./titolo:Multiple molecular pathways in melanomagenesis: Characterization of therapeutic targets/doi:10.3389%2Ffonc.2015.00183/rivista:Frontiers in oncology/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume:5
Frontiers in Oncology, Vol 5 (2015)
Molecular mechanisms involved in pathogenesis of malignant melanoma have been widely studied and novel therapeutic treatments developed in recent past years. Molecular targets for therapy have mostly been recognized in the RAS-RAF-MEK-ERK and PI3K-AK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b813672106c5f813aa244adbafb3ed3d
https://doi.org/10.3389/fonc.2015.00183
https://doi.org/10.3389/fonc.2015.00183